Hers Health, Inc. Reports Third Quarter 2026 Financial Results
AIThis post was created with the assistance of artificial intelligence (AI).

TL;DR

For listenersOffer from Amazon

Turn quiet afternoons into listening time

  • Thousands of audiobooks, podcasts and originals
  • Listen on your phone, tablet or Echo — also offline
  • Cancel anytime
Try Audible free Free trial for new members
As an affiliate, we earn on qualifying purchases.

Hims & Hers reported third-quarter 2026 revenue of $890.4 million, up 49% year over year, while subscribers rose 13% to nearly 2.8 million. The company posted a $33 million net loss, and lowered its full-year Adjusted EBITDA outlook to $257 million-$277 million while forecasting $3.13 billion-$3.15 billion in revenue.

Hims & Hers Health reported $890.4 million in third-quarter 2026 revenue, up 49% from a year earlier, but recorded a $33 million net loss and cut its full-year Adjusted EBITDA guidance. The telehealth company said subscribers reached nearly 2.8 million, as investors weigh its rapid sales growth against weaker margins and lower cash generation.

Revenue for the three months ended September 30 rose from $599.0 million in the same quarter of 2025. The company reported 57% gross margin, down from 74% a year earlier. Net results shifted from $15.8 million in net income in the third quarter of 2025 to a $33.0 million loss this quarter.

Adjusted EBITDA, a non-GAAP measure, was $82.4 million, compared with $78.4 million in the prior-year quarter. Net cash provided by operating activities fell to $65.4 million from $148.7 million, while free cash flow declined to $26.0 million from $79.4 million. The company said its release includes reconciliations of these non-GAAP measures to the closest comparable U.S. GAAP measures.

Subscribers at quarter-end totaled 2.788 million, up 13% year over year. Monthly revenue per average subscriber was reported at $105, compared with $81 for the third quarter of 2025. U.S. revenue increased 21% to $657.1 million; revenue from the rest of the world rose 321% to $233.3 million. The company’s release reported both regional figures and the total, but did not explain in the provided material how international growth was distributed among markets.

At a glance
reportWhen: Announced November 9, 2026; quarter end…
The developmentHims & Hers released third-quarter 2026 results showing sharply higher revenue alongside lower gross margin, a net loss and reduced full-year Adjusted EBITDA guidance.

Growth Meets Margin Pressure

The results show fast revenue growth alongside a marked decline in gross margin and lower cash flow from operations. That combination matters because it can affect how much the company can invest in expanding services while still improving profitability. The reported figures do not, by themselves, establish why margins declined or whether the change will persist.

The guidance puts that tension in focus. Hims & Hers expects full-year revenue of $3.13 billion to $3.15 billion, while projecting Adjusted EBITDA of $257 million to $277 million, equivalent to an 8% to 9% margin. Adjusted EBITDA is not a U.S. GAAP measure, and the company cautioned that actual results may differ from its outlook.

For customers and shareholders, subscriber growth and the company’s international expansion point to a broader platform, while the loss and reduced cash generation raise questions about the cost of that growth. The earnings release provides headline results but not enough detail to resolve those questions on its own.

As an affiliate, we earn on qualifying purchases.

Regional Sales and Subscriber Growth

Hims & Hers sells health and wellness services through a digital platform. In the quarter, its reported U.S. revenue reached $657.1 million, compared with $543.5 million a year earlier. Rest-of-world revenue rose from $55.5 million to $233.3 million. For the first nine months of 2026, total revenue was $2.252 billion, up 30% from $1.730 billion in the comparable 2025 period.

The company characterized this quarter as its second consecutive quarter of revenue growth acceleration. CFO Yemi Okupe said domestic revenue increased 21% year over year and international revenue grew more than 300%. Those are management’s descriptions of the reported results; the release does not provide a breakdown of the specific factors driving the regional changes.

CEO Andrew Dudum also pointed to planned expansions in treatments and specialties, and to an AI-supported customer experience. These are company initiatives described in the release, not reported financial outcomes. The company said it paced marketing spending ahead of planned fourth-quarter expansions, but the announcement did not quantify that spending decision’s effect on the quarter’s margins.

“Today, customers want real choice, real value, and a care team that knows them.”

— Andrew Dudum, Hims & Hers co-founder and chief executive

Key Drivers Still Need Detail

The release reports lower gross margin, net loss and lower operating cash flow, but the supplied material does not break down the reasons for those year-over-year changes. It is also not clear from the announcement how much of international revenue growth came from customer additions, pricing, acquisitions or other factors.

The company’s revenue and Adjusted EBITDA projections are forward-looking estimates, not guaranteed outcomes. Hims & Hers said actual results could differ materially. It did not reconcile its forward-looking Adjusted EBITDA outlook to forecast net income or loss, saying it could not predict certain components with reasonable certainty without unreasonable effort.

The release describes planned platform expansions but does not detail their timing, cost or expected contribution to future revenue and earnings. The available information also does not establish whether the quarter’s lower margins and cash flow reflect temporary investment decisions or a longer-running trend.

Fourth-Quarter Outlook and Call

For the fourth quarter of 2026, Hims & Hers forecast $875 million to $895 million in revenue and $70 million to $90 million in Adjusted EBITDA, corresponding to an 8% to 10% margin. Its full-year revenue outlook is $3.13 billion to $3.15 billion, with full-year Adjusted EBITDA expected at $257 million to $277 million and an 8% to 9% margin.

The company scheduled a conference call to review the results for November 9, 2026, at 5 p.m. Eastern, with a live audio webcast through its investor-relations website. Further management commentary on margins, cash flow, marketing investment and planned expansions may clarify how the company views the quarter’s results and the year-end outlook. The guidance remains subject to the risks described in the company’s release.

Key Questions

How much revenue did Hims & Hers report for the third quarter?

Hims & Hers reported $890.4 million in revenue for the quarter ended September 30, 2026, up 49% from $599.0 million a year earlier.

Was the company profitable in the quarter?

No. The company reported a $33.0 million net loss, compared with net income of $15.8 million in the third quarter of 2025.

How many subscribers did Hims & Hers have?

It reported 2.788 million subscribers at the end of the quarter, 13% more than a year earlier.

What is the company’s full-year 2026 outlook?

Hims & Hers forecast $3.13 billion to $3.15 billion in revenue and $257 million to $277 million in Adjusted EBITDA. The company cautioned that actual results may differ from its forward-looking estimates.

Source: investors.hims.com

This article is for informational purposes only and is not medical advice. Always consult a qualified healthcare professional about your specific situation.
You May Also Like

Upfront TAVR May Be The Way Forward In Moderate Aortic Stenosis, Trial Suggests

In PROGRESS, upfront TAVR lowered a two-year death-or-heart-failure composite versus surveillance in moderate aortic stenosis patients with risk features.

‘Tech Is Not Good Or Bad, But Neither Is It Neutral’: What We Heard This Week

MedPage Today’s October 18 roundup collected expert comments on AI in health care, a new flu shot, pregnancy, HIV, transplantation and more.

Do These Four Stretches After Walking To Maintain Your Mobility And Keep Stiffness At Bay

A physical therapist recommends four post-walk stretches for key muscle groups, with guidance on duration, technique and safety.

When You Think You Know Yourself, But You’re Wrong

A Tiny Buddha essay by a 70-year-old executive coach examines how fixed self-descriptions can limit choices and how to question them.